---
category: news
title: "KidneyIntelX Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time"
excerpt: "Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces new data demonstrating KidneyIntelX can be effective at monitoring therapeutic response and improvements in kidney health over time in adults with type 2 diabetes."
publishedDateTime: 2021-06-28T11:00:00Z
originalUrl: "https://www.wallstreet-online.de/nachricht/14089480-kidneyintelx-enables-monitoring-of-sglt2-inhibitor-therapy-response-and-corresponding-risk-reduction-over-time/all"
webUrl: "https://www.wallstreet-online.de/nachricht/14089480-kidneyintelx-enables-monitoring-of-sglt2-inhibitor-therapy-response-and-corresponding-risk-reduction-over-time/all"
type: article
quality: 0
heat: 0
published: false

provider:
  name: wallstreet online
  domain: wallstreet-online.de

topics:
  - AI in Healthcare
  - AI

secured: "OmBkZZhne/g/b857k9WTMFgJvUmTVXg1LTA7JNrX2QckT43eHoxznvabQjqFJLI84+VTZ+tYgUx5cF7TUJYLZsMBBWCnFyKIVw6z4Zt8EzYZA1CSUf9thR0kqlCzISfXuiwpO+/AHScUkF7/6mG1zTkzNdSECVdsVU8N3xJLYVQQr/8VwiAUza3E6i+XMaoxJVK6jpEl9xL/c8uwEJARQOweGPAFOVvAuAtSynVRLhjKlmmUgE/lvm4n488tB/JE8AgXW8enkq7lTMN3wRomgg8DJKYITKpb2J5ObxG52DtCrW479jGevRhOvoI58rDxnPfzprPos8a6Z3jt/kP/feO0BIVggOJkneF+CmUcI1E=;BvaBBRk4oqfNBgSueccufA=="
---

